Additionally, excess Alk expression or activation has been reported in astrocytomas, gliomas, neuroblastomas and pheochromocytomas, in which loss of NF1 expression has also been found [11], [13]–[17], [63]. This evidence concerns the gene NF1 and central nervous system cancer.